Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Japanese Yen remains on the front foot vs weak USD after hawkish BoJ Minutes

The USD/JPY pair struggles to capitalize on the previous day's goodish rebound from the 157.40 area, or the weekly low, attracting some sellers for the second straight day on Thursday.

Japanese Yen remains on the front foot vs weak USD after hawkish BoJ Minutes

The USD/JPY currency pair is struggling to build on its recent gains, as traders await a decisive move below 158.00 to position for further losses. Minutes from the Bank of Japan's September meeting indicate policymakers' consensus to continue raising interest rates and adjust monetary easing, which has bolstered the Japanese Yen.

The US Dollar's decline has been fueled by Democrats' control of Congress, concerns over fiscal gridlock, and the prospect of an end to the Iran war, leading to a drop in crude oil prices and lower US bond yields. Despite hawkish Federal Reserve expectations, which might support the US Dollar, the upcoming US Nonfarm Payrolls report on Friday will likely drive USD demand.

While the USD/JPY pair remains bearish in the short term, a daily close above the 200-day Simple Moving Average at 158.65 could indicate a shift in momentum and open the door to a recovery. For now, any recovery in the USD/JPY pair is likely to face selling pressure as Japanese authorities may step in to support the domestic currency.

Written by urgent.news from FXStreet's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at fxstreet.com →

More in Finance & Markets

Novo Nordisk: 3 Key Takeaways for Long-Term Investors

U.S. pricing pressure weighs on Novo Nordisk's growth, but management is counting on the pipeline to offset it over the long haul.

  • Novo Nordisk reported stronger-than-expected full-year financial guidance in Q3 2026 earnings call.
  • Patient base expanded by 1.3 million in a single quarter, indicating robust volume growth.

More from Thursday 5 November →